Jaroslav Veselý

Inhibition of Cyclin‐Dependent Kinases by Purine Analogues

Jaroslav Veselý, Libor Havlı́ček, Miroslav Strnad et al. · European Journal of Biochemistry · 1994 · 625 citations · Full text

Multiple modes of ligand recognition: Crystal structures of cyclin‐dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine

Ursula Schulze‐Gahmen, Jeroen Brandsen, Heather D. Jones et al. · Proteins Structure Function and Bioinformatics · 1995 · 275 citations

Molecular Biology, Cell Cycle, Chemical Biology +22

Cytokinin-Derived Cyclin-Dependent Kinase Inhibitors:  Synthesis and cdc2 Inhibitory Activity of Olomoucine and Related Compounds

Libor Havlı́ček, Jan Hanuš, Jaroslav Veselý et al. · Journal of Medicinal Chemistry · 1997 · 240 citations · Full text

High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors

Ilona Hapková, Jozef Škarda, Caroline Rouleau et al. · Experimental and Molecular Pathology · 2013 · 34 citations · Full text

Tumor Biology, Gastrointestinal Oncology, Rna Binding Proteins +12

In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route.

Z Chmela, Jaroslav Veselý, Karel Lemr et al. · PubMed · 2001 · 29 citations

Cellular Pharmacology, Pharmacotherapy, Experimental Pharmacology +21